TriSalus Life Sciences, Inc. (TLSIW) Net margin 2022–2025
TriSalus Life Sciences, Inc. (TLSIW) net profit margin by fiscal year — reported net income divided by reported revenue.
-86.9%FY2025 · since FY2022: -380.6% → -86.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -86.9% | +15.2 pp |
| FY2024 | -102.1% | +218.6 pp |
| FY2023 | -320.7% | +59.9 pp |
| FY2022 | -380.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSIW financial trends
TLSIW RevenueTLSIW Net incomeTLSIW Gross profitTLSIW Gross marginTLSIW Operating incomeTLSIW Operating marginTLSIW Operating cash flowTLSIW Free cash flowTLSIW Capital expendituresTLSIW Return on equityTLSIW Stock buybacksTLSIW Dividends paidTLSIW Total assetsTLSIW Total liabilitiesTLSIW Shareholders’ equityTLSIW overview →